Who Is AstraZeneca UK Limited?
AstraZeneca UK Limited is the British division of AstraZeneca plc, a global, science-led biopharmaceutical company focused on the discovery, development, and commercialisation of prescription medicines.
Headquartered at 1 Francis Crick Avenue, Cambridge Biomedical Campus, AstraZeneca UK is an integral part of the company’s global network, contributing significantly to its mission of transforming healthcare through science.
Operating since 1998, AstraZeneca UK leads in therapeutic innovations, particularly across Oncology, Cardiovascular, Renal and Metabolism (CVRM), Respiratory & Immunology, Rare Diseases, and Vaccines & Immune Therapies.
With a strong commitment to R&D, it houses one of Europe’s most advanced scientific research centres in Cambridge.
Driven by the vision to improve patient outcomes and promote sustainable healthcare, AstraZeneca UK is actively shaping the future of life sciences in the UK, positioning itself as a strategic partner to the NHS, academia, biotech, and government stakeholders.
As a company operating under SIC Code 70100 – Activities of Head Offices, AstraZeneca UK Limited is a cornerstone in the global biopharmaceutical ecosystem, serving as a key research, development, and commercial hub within the AstraZeneca family.
Who Are the Key Directors of AstraZeneca UK Limited?
AstraZeneca UK Limited’s leadership is shaped by a diverse group of seasoned professionals with expertise spanning global healthcare, corporate strategy, scientific research, and pharmaceutical innovation.
This multi-disciplinary leadership structure allows the company to drive forward scientific breakthroughs while remaining strategically agile in both domestic and international markets.
Below is a snapshot of the directors, their appointment dates, and backgrounds:
| Director Name | Appointed On | Experience & Background |
|---|---|---|
| Pascal Claude Roland Soriot | 1 October 2012 | CEO with a global healthcare leadership background |
| Aradhana Sarin | 2 August 2021 | Company Director, based in the United States |
| Rudi Dobber | 27 June 2024 | Senior pharma executive with global experience |
| Caterina Brindicci | 27 June 2024 | Medical and scientific expert |
| Susan Galbraith | 27 June 2024 | Oncology research and development leader |
| Alexander De Giorgio-Miller | 27 June 2024 | Strategic development and corporate operations |
| Lutz Jermutus | 10 February 2025 | Corporate director with clinical trial expertise |
| Elaine Harrop | 27 June 2024 | Director with focus on global medicines access |
| Pablo Panella | 27 June 2024 | Market access and portfolio development |
| Sally Sambrook | 27 June 2024 | Commercial and medical affairs leader |
| Christine Stephens | 27 June 2024 | Compliance and regulatory governance |
| Iain Alistair Collins | 31 May 2017 | Senior advisor with operational insight |
This leadership team exemplifies AstraZeneca’s mission to improve health outcomes globally through scientific excellence and ethical corporate governance.
What Are the Company Details of AstraZeneca UK Limited?
Incorporated on 26 November 1998, AstraZeneca UK Limited is a private limited company registered in England and Wales under Company Number 03674842. The firm’s registered office is located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA.
AstraZeneca UK plays a pivotal role in the global operations of AstraZeneca plc, particularly known for co-developing the Oxford-AstraZeneca COVID-19 vaccine.
Company Summary
| Detail | Information |
|---|---|
| Registered Office | 1 Francis Crick Avenue, Cambridge, CB2 0AA |
| UK Presence | Cambridge (HQ) |
| Last Accounts Made Up To | 31 December 2023 |
| Next Accounts Due | 30 September 2025 |
| Last Confirmation Statement | 26 November 2024 |
| Next Confirmation Due | 10 December 2025 |
Though financials are consolidated under AstraZeneca plc, the UK arm remains financially robust and compliant. Notably, AstraZeneca plc reported $45.8 billion in revenue for 2023 and continues major investments in the UK, including a £1 billion R&D centre in Cambridge.
AstraZeneca UK stands at the forefront of innovation, contributing significantly to global healthcare solutions while reinforcing the UK’s position as a leader in pharmaceutical development.
What Services and Solutions Does AstraZeneca UK Provide?
AstraZeneca UK Limited offers a wide spectrum of biopharmaceutical services, ranging from drug research and clinical trials to production, supply chain management, and patient support programmes.
Key Focus Areas
- Oncology: Advanced treatments for lung, breast, prostate, and blood cancers.
- Cardiovascular, Renal & Metabolism (CVRM) – Innovations in heart disease, diabetes, and chronic kidney conditions.
- Respiratory & Immunology: Solutions for asthma, COPD, and immune-related diseases.
- Rare Disease: Specialised therapies developed through its rare disease arm, Alexion.
- Vaccines & Immune Therapies: Strategic immunisation solutions and pandemic response readiness.
Strategic Features and Initiatives
| Feature | Description |
| Global R&D Integration | Research collaboration across global sites with a UK focus |
| Clinical Trials in the UK | Partnering with NHS and academic networks for drug development |
| AI and Digital Health | Leveraging AI for diagnostics, trials, and personalised treatment |
| Environmental Sustainability | Committed to carbon neutrality and ethical sourcing |
| NHS Partnership Programmes | Co-developing care models and access strategies for UK patients |
AstraZeneca UK is also driving early disease identification and prevention strategies through its digital innovation and public-private healthcare collaborations.
How Can You Contact AstraZeneca UK Limited?
AstraZeneca UK offers direct lines of communication for patients, healthcare professionals, researchers, and partners.
Contact Details
| Contact Type | Information |
| Business Name | AstraZeneca UK Limited |
| Registered Address | 1 Francis Crick Avenue, Cambridge, CB2 0AA |
| Phone (UK) | 0800 783 0033 |
| General Medical Enquiries Email | Medical.InformationUK@astrazeneca.com |
| Supply Chain Enquiries | supply.chain@astrazeneca.com |
| Website | www.astrazeneca.co.uk |
The UK website is tailored specifically for individuals seeking information about AstraZeneca’s operations, therapies, and opportunities within the United Kingdom.
Why Should Healthcare Stakeholders Trust AstraZeneca UK?
AstraZeneca UK Limited is a leading voice in the UK healthcare ecosystem. With a legacy of breakthrough innovations, strategic partnerships, and public health contributions, it continues to enhance the UK’s position as a global life sciences hub.
Key Strengths
- Cutting-Edge R&D: Home to world-class facilities and partnerships in Cambridge.
- Scientific Leadership: Continuous innovation in therapy development.
- Healthcare Partnerships: Deep ties with the NHS and academic institutions.
- Patient-Centric Values: Focus on equity in medicine access and quality of care.
- Sustainable Commitments: Aligned with global environmental health goals.
With a strategic base in the UK and a globally integrated scientific approach, AstraZeneca UK Limited remains at the forefront of transforming healthcare for the better.
